EXAS

EXAS

USD

Exact Sciences Corporation Common Stock

$69.590-0.480 (-0.685%)

即時價格

Healthcare
Diagnostics & Research
美國

價格圖表

Loading Chart...

關鍵指標

市場指標
公司基本面
交易統計

市場指標

開盤

$70.070

最高

$72.810

最低

$67.970

交易量

1.54M

公司基本面

市值

13.2B

行業

Diagnostics & Research

國家

United States

交易統計

平均交易量

2.95M

交易所

NCM

貨幣

USD

52週範圍

最低 $38.81當前 $69.590最高 $72.83

相關新聞

Analyst Upgrades

TD Cowen Maintains Buy on Exact Sciences, Raises Price Target to $90

TD Cowen analyst Dan Brennan maintains Exact Sciences with a Buy and raises the price target from $74 to $90.

查看更多
TD Cowen Maintains Buy on Exact Sciences, Raises Price Target to $90
Analyst Upgrades

Baird Maintains Outperform on Exact Sciences, Raises Price Target to $88

Baird analyst Catherine Schulte maintains Exact Sciences with a Outperform and raises the price target from $72 to $88.

查看更多
Baird Maintains Outperform on Exact Sciences, Raises Price Target to $88
Analyst Upgrades

Benchmark Maintains Buy on Exact Sciences, Raises Price Target to $75

Benchmark analyst Bruce D. Jackson maintains Exact Sciences with a Buy and raises the price target from $60 to $75.

查看更多
Benchmark Maintains Buy on Exact Sciences, Raises Price Target to $75
Analyst Upgrades

Guggenheim Maintains Buy on Exact Sciences, Raises Price Target to $75

Guggenheim analyst Subbu Nambi maintains Exact Sciences with a Buy and raises the price target from $70 to $75.

查看更多
Guggenheim Maintains Buy on Exact Sciences, Raises Price Target to $75
Analyst Upgrades

Barclays Maintains Overweight on Exact Sciences, Raises Price Target to $77

Barclays analyst Luke Sergott maintains Exact Sciences with a Overweight and raises the price target from $65 to $77.

查看更多
Barclays Maintains Overweight on Exact Sciences, Raises Price Target to $77
Analyst Upgrades

Stifel Maintains Buy on Exact Sciences, Raises Price Target to $80

Stifel analyst Daniel Arias maintains Exact Sciences with a Buy and raises the price target from $67 to $80.

BusinessWire

Exact Sciences to Participate in November Investor Conference

Exact Sciences Corp. (NASDAQ:EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conference and invited investors to participate